Dr. Jenny Guerre, MD

Dr. Guerre practices at Ochsner LSU Health - Academic Medical Center in Shreveport, Louisiana, part of Ochsner Health System.

Dr. Guerre's NPI, 1063559789, was assigned on January 31, 2007. Dr. Guerre graduated from University of Haiti in 1999. Dr. Guerre holds Louisiana license MD.206337.

Dr. Guerre's primary practice is Ochsner LSU Health - Academic Medical Center, at 1541 Kings Highway, Shreveport, LA 71130 in Caddo Parish. The practice phone is (318) 675-5058.

Dr. Guerre's primary practice is Ochsner LSU Health - Academic Medical Center in Shreveport, Louisiana, part of Ochsner Health System. Dr. Guerre is also affiliated with Ochsner LSU Health - St. Mary Medical Center. The medical group on file is LSU Health Shreveport. Dmand AI also links Dr. Guerre to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Guerre practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Guerre's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Guerre is licensed in Louisiana.

Dmand AI lists epilepsy, fibromyalgia and chronic pain, hereditary polyneuropathy, lower back pain, muscle disease, muscle weakness and seizures among the conditions Dr. Guerre treats.

CMS data shows 257 Medicare services from Dr. Guerre across 5 procedure codes in 2024, for 109 Medicare patients. Medicare paid $12,210 for them.

CMS counts 109 Medicare patients who saw Dr. Guerre in 2024. The largest group is 65 to 74, with 47 patients. 75% of them have high blood pressure, and 61% have high cholesterol. 46% are also on Medicaid. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Guerre's median patient age at 59, with 63% women.

In 2024, Dr. Guerre wrote 871 Medicare Part D claims for 113 patients. 78% of them were for generic drugs. CMS names the drug for 718 of them, across 27 drugs with 11 or more claims each, at $1,725,960 in total drug cost. In 2023, CMS named 463 claims across 19 drugs.

Dr. Guerre accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 712 general payments to Dr. Guerre from 52 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 57% of the total. Argenx US, Inc. paid the most, $7,433.

Dr. Guerre graduated from University of Haiti in 1999.

Dr. Guerre is in network with 13 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.